deferoxamine has been researched along with Muscle Disorders in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Excerpt | Relevance | Reference |
---|---|---|
" Further experience with DFO is needed, both to identify the optimal dosage and to clarify the risks of long-term therapy in patients with renal failure." | 2.37 | Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine. ( Coburn, JW; Norris, KC, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sikole, A | 1 |
Stojkovski, L | 1 |
Cakalaroski, K | 1 |
Stojcev, N | 1 |
Amitov, V | 1 |
Polenakovic, M | 1 |
Coburn, JW | 1 |
Norris, KC | 1 |
1 review available for deferoxamine and Muscle Disorders
Article | Year |
---|---|
Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine.
Topics: Aluminum; Bone Diseases; Deferoxamine; Hematologic Diseases; Humans; Muscular Diseases; Pain; Risk | 1986 |
1 other study available for deferoxamine and Muscle Disorders
Article | Year |
---|---|
Successful treatment of soft tissue calcifications in uremia.
Topics: Buttocks; Calcinosis; Deferoxamine; Diphosphonates; Drug Therapy, Combination; Female; Humans; Kidne | 2006 |